MBX Biosciences, Inc. — Form D/A
MBX Biosciences, Inc. of CARMEL, IN, a company, filed a Form D amendment with the SEC on 2019-05-10. The offering totals $5.0M, of which $2.3M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2019-05-10
- Form: D/A
- Accession: 0001776111-19-000002
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $2.3M
- Remaining: $2.7M
- Investors: 9
- Date of first sale: 2019-04-25
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-339344
Issuer
- Name: MBX Biosciences, Inc.
- CIK: 0001776111
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 11711 N. Meridian Street, Suite 300, CARMEL, IN, 46032
- Phone: 317-659-0200
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| James M Cornelius | Director | Carmel, IN |
| Patrick M Heron | Director | Carmel, IN |
| Edward M Mathers | Director | Carmel, IN |
| Richard Kent DiMarchi | Director | Carmel, IN |
| Richard Kent DiMarchi | Executive Officer | Carmel, IN |
| Tiba M Aynechi | Director | Carmel, IN |
| Peter Kent Hawryluk | Director | Carmel, IN |
| Peter Kent Hawryluk | Executive Officer | Carmel, IN |
| Ora Kent Pescovitz | Director | Carmel, IN |
| Carl M Gordon | Director | Carmel, IN |
| Richard M Bartram | Executive Officer | Carmel, IN |
| Timothy Kent Knickerbocker | Director | Carmel, IN |
| Timothy Kent Knickerbocker | Executive Officer | Carmel, IN |
Other filings by this issuer (3)
More